Otsuka Pharmaceutical | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Deals

26 September 2024

Sanofi sees promise in CD73

Deals

9 July 2024

Arcus gets anti-CD73 small molecule buy-in

Conferences Trial results

13 October 2023

Triple meeting 2023 – Relay shifts to a tumour-agnostic plan

The company’s FGFR2 inhibitor shows potential beyond cholangiocarcinoma, but the markets aren’t buying it.

Trial results

3 August 2023

Taiho takes front-line zipalertinib into phase 3

Subscribe to Otsuka Pharmaceutical